262 related articles for article (PubMed ID: 27645259)
1. ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase.
Zhakupova A; Debeuf N; Krols M; Toussaint W; Vanhoutte L; Alecu I; Kutalik Z; Vollenweider P; Ernst D; von Eckardstein A; Lambrecht BN; Janssens S; Hornemann T
FASEB J; 2016 Dec; 30(12):4289-4300. PubMed ID: 27645259
[TBL] [Abstract][Full Text] [Related]
2. ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis.
Siow D; Sunkara M; Dunn TM; Morris AJ; Wattenberg B
J Lipid Res; 2015 Apr; 56(4):898-908. PubMed ID: 25691431
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells.
Kiefer K; Carreras-Sureda A; García-López R; Rubio-Moscardó F; Casas J; Fabriàs G; Vicente R
J Biol Chem; 2015 Jan; 290(5):2822-30. PubMed ID: 25519910
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids and Asthma.
Worgall TS
Adv Exp Med Biol; 2022; 1372():145-155. PubMed ID: 35503179
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways.
Bugajev V; Paulenda T; Utekal P; Mrkacek M; Halova I; Kuchar L; Kuda O; Vavrova P; Schuster B; Fuentes-Liso S; Potuckova L; Smrz D; Cernohouzova S; Draberova L; Bambouskova M; Draber P
J Lipid Res; 2021; 62():100121. PubMed ID: 34560079
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells.
Gupta SD; Gable K; Alexaki A; Chandris P; Proia RL; Dunn TM; Harmon JM
J Biol Chem; 2015 Jan; 290(1):90-8. PubMed ID: 25395622
[TBL] [Abstract][Full Text] [Related]
7. Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model.
Kiefer K; Casas J; García-López R; Vicente R
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897694
[TBL] [Abstract][Full Text] [Related]
8. Human Rhinovirus Infection of the Respiratory Tract Affects Sphingolipid Synthesis.
Wasserman E; Gomi R; Sharma A; Hong S; Bareja R; Gu J; Balaji U; Veerappan A; Kim BI; Wu W; Heras A; Perez-Zoghbi J; Sung B; Gueye-Ndiaye S; Worgall TS; Worgall S
Am J Respir Cell Mol Biol; 2022 Mar; 66(3):302-311. PubMed ID: 34851798
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 deletion of ORMDLs reveals complexity in sphingolipid metabolism.
Green CD; Weigel C; Oyeniran C; James BN; Davis D; Mahawar U; Newton J; Wattenberg BW; Maceyka M; Spiegel S
J Lipid Res; 2021; 62():100082. PubMed ID: 33939982
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids, ORMDL3 and asthma: what is the evidence?
Worgall TS
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):99-103. PubMed ID: 28030368
[TBL] [Abstract][Full Text] [Related]
11. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity.
Worgall TS; Veerappan A; Sung B; Kim BI; Weiner E; Bholah R; Silver RB; Jiang XC; Worgall S
Sci Transl Med; 2013 May; 5(186):186ra67. PubMed ID: 23698380
[TBL] [Abstract][Full Text] [Related]
12. The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes.
Davis DL; Gable K; Suemitsu J; Dunn TM; Wattenberg BW
J Biol Chem; 2019 Mar; 294(13):5146-5156. PubMed ID: 30700557
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex.
Li S; Xie T; Liu P; Wang L; Gong X
Nat Struct Mol Biol; 2021 Mar; 28(3):249-257. PubMed ID: 33558762
[TBL] [Abstract][Full Text] [Related]
14. Orm/ORMDL proteins: Gate guardians and master regulators.
Davis D; Kannan M; Wattenberg B
Adv Biol Regul; 2018 Dec; 70():3-18. PubMed ID: 30193828
[TBL] [Abstract][Full Text] [Related]
15. Orosomucoid-like 3 Supports Rhinovirus Replication in Human Epithelial Cells.
Liu Y; Bochkov YA; Eickhoff JC; Hu T; Zumwalde NA; Tan JW; Lopez C; Fichtinger PS; Reddy TR; Overmyer KA; Gumperz JE; Coon J; Mathur SK; Gern JE; Smith JA
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):783-792. PubMed ID: 32078788
[TBL] [Abstract][Full Text] [Related]
16. The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice.
Debeuf N; Zhakupova A; Steiner R; Van Gassen S; Deswarte K; Fayazpour F; Van Moorleghem J; Vergote K; Pavie B; Lemeire K; Hammad H; Hornemann T; Janssens S; Lambrecht BN
J Allergy Clin Immunol; 2019 Dec; 144(6):1648-1659.e9. PubMed ID: 31330218
[TBL] [Abstract][Full Text] [Related]
17. ORMDL3 and Asthma: Linking Sphingolipid Regulation to Altered T Cell Function.
Luthers CR; Dunn TM; Snow AL
Front Immunol; 2020; 11():597945. PubMed ID: 33424845
[No Abstract] [Full Text] [Related]
18. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice.
Hojjati MR; Li Z; Jiang XC
Biochim Biophys Acta; 2005 Oct; 1737(1):44-51. PubMed ID: 16216550
[TBL] [Abstract][Full Text] [Related]
19. The role of ORMDL proteins, guardians of cellular sphingolipids, in asthma.
Paulenda T; Draber P
Allergy; 2016 Jul; 71(7):918-30. PubMed ID: 26969910
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Naumova AK; Radzioch D
J Pharmacol Exp Ther; 2020 Jun; 373(3):476-487. PubMed ID: 32273303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
